18 peptides are currently in the category 2 list, which means they cannot be compounded by US pharmacies, for reference (yet). HHS Peptides Move: Compounding Pharmacy Concerns Scott Brunner, CAE posted on the topic LinkedIn FDA Evaluates Peptides for Section 503A Compounding List Lance Liberti, MBA, BCPA posted on the topic LinkedIn BIG NEWS IN THE PEPTIDE COMMUNITY On April 15, 2026, the FDA announced it is removing 12 peptides from its Category 2 significant safety concerns list and this changes everything for
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
dsip list 🚨BREAKING NEWS: HHS @seckennedy just announced that the FDA is taking a step toward restoring science-based access by removing 12 peptides from Category 2. FDA is moving them to an independent scientific